• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Radiotherapy: radioiodine in thyroid cancer-how to minimize side effects.

作者信息

Reiners Christoph, Luster Markus

出版信息

Nat Rev Clin Oncol. 2012 Jun 19;9(8):432-4. doi: 10.1038/nrclinonc.2012.101.

DOI:10.1038/nrclinonc.2012.101
PMID:22710337
Abstract
摘要

相似文献

1
Radiotherapy: radioiodine in thyroid cancer-how to minimize side effects.放射治疗：甲状腺癌中的放射性碘——如何将副作用降至最低
Nat Rev Clin Oncol. 2012 Jun 19;9(8):432-4. doi: 10.1038/nrclinonc.2012.101.
2
Blood and bone marrow dosimetry in radioiodine therapy of thyroid cancer.甲状腺癌放射性碘治疗中的血液和骨髓剂量测定
J Nucl Med. 2005 May;46(5):899-900; author reply 901.
3
Does lemon candy decrease salivary gland damage after radioiodine therapy for thyroid cancer?柠檬糖能否降低甲状腺癌放射性碘治疗后的唾液腺损伤？
J Nucl Med. 2005 Feb;46(2):261-6.
4
Blood dosimetry and dose-rate effects after radioiodine therapy of differentiated thyroid cancer.分化型甲状腺癌放射性碘治疗后的血液剂量测定及剂量率效应
J Nucl Med. 2005 May;46(5):899.
5
Patient release issue reopened.
J Nucl Med. 2010 Dec;51(12):13N.
6
Recombinant human thyrotropin (rhTSH) versus Levo-thyroxine withdrawal in radioiodine therapy of differentiated thyroid cancer patients: differences in abdominal absorbed dose.重组人促甲状腺激素（rhTSH）与左旋甲状腺素停药在分化型甲状腺癌患者放射性碘治疗中的比较：腹部吸收剂量的差异。
Endocrine. 2019 Jul;65(1):132-137. doi: 10.1007/s12020-019-01897-x. Epub 2019 Mar 14.
7
Blood and bone marrow dosimetry in radioiodine therapy of differentiated thyroid cancer after stimulation with rhTSH.重组人促甲状腺素刺激后分化型甲状腺癌放射性碘治疗中的血液和骨髓剂量测定
J Nucl Med. 2005 May;46(5):900-1; author reply 901.
8
Professional groups respond.
J Nucl Med. 2010 Dec;51(12):13N.
9
Respiratory distress caused by radioiodine therapy in patients with differentiated thyroid cancer.
Ann Nucl Med. 2006 Aug;20(7):499-502. doi: 10.1007/BF02987260.
10
Effect of reserpine on salivary gland radioiodine uptake in thyroid cancer.利血平对甲状腺癌唾液腺放射性碘摄取的影响。
Clin Nucl Med. 1987 Apr;12(4):303-7. doi: 10.1097/00003072-198704000-00014.

引用本文的文献

1
Advancements in the treatment of differentiated thyroid cancer.分化型甲状腺癌治疗的进展
Ther Adv Endocrinol Metab. 2021 Mar 17;12:20420188211000251. doi: 10.1177/20420188211000251. eCollection 2021.
2
A Carboxy-Terminal Monoleucine-Based Motif Participates in the Basolateral Targeting of the Na+/I- Symporter.一个羧基末端单亮氨酸基序参与钠/碘同向转运体的基底外侧靶向。
Endocrinology. 2019 Jan 1;160(1):156-168. doi: 10.1210/en.2018-00603.

本文引用的文献

1
Radioiodine for thyroid cancer--is less more?用于甲状腺癌治疗的放射性碘——少即是多？
N Engl J Med. 2012 May 3;366(18):1732-3. doi: 10.1056/NEJMe1202172.
2
Ablation with low-dose radioiodine and thyrotropin alfa in thyroid cancer.甲状腺癌的低剂量碘 131 消融联合促甲状腺激素治疗。
N Engl J Med. 2012 May 3;366(18):1674-85. doi: 10.1056/NEJMoa1109589.
3
Strategies of radioiodine ablation in patients with low-risk thyroid cancer.低危甲状腺癌患者的碘 131 消融策略。
N Engl J Med. 2012 May 3;366(18):1663-73. doi: 10.1056/NEJMoa1108586.
4
Radioiodine for remnant ablation and therapy of metastatic disease.放射性碘用于转移病灶的残余消融和治疗。
Nat Rev Endocrinol. 2011 Aug 9;7(10):589-95. doi: 10.1038/nrendo.2011.134.
5
No survival difference after successful (131)I ablation between patients with initially low-risk and high-risk differentiated thyroid cancer.在最初低危和高危分化型甲状腺癌患者中，成功的 (131)I 消融治疗后无生存差异。
Eur J Nucl Med Mol Imaging. 2010 Feb;37(2):276-83. doi: 10.1007/s00259-009-1315-6. Epub 2009 Nov 29.
6
Second primary malignancy risk after radioactive iodine treatment for thyroid cancer: a systematic review and meta-analysis.甲状腺癌放射性碘治疗后的第二原发性恶性肿瘤风险：一项系统评价和荟萃分析。
Thyroid. 2009 May;19(5):451-7. doi: 10.1089/thy.2008.0392.
7
Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or hormone withdrawal.甲状腺癌放射性碘治疗中的碘生物动力学与剂量学：促甲状腺激素释放激素（rhTSH）或激素撤减后消融的前瞻性国际对照研究的程序与结果
J Nucl Med. 2006 Apr;47(4):648-54.
8
A comparison of short-term changes in health-related quality of life in thyroid carcinoma patients undergoing diagnostic evaluation with recombinant human thyrotropin compared with thyroid hormone withdrawal.与甲状腺激素撤药相比，接受重组人促甲状腺素诊断评估的甲状腺癌患者健康相关生活质量的短期变化比较。
J Clin Endocrinol Metab. 2006 Mar;91(3):878-84. doi: 10.1210/jc.2005-2064. Epub 2006 Jan 4.
9
Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin in differentiated thyroid carcinoma: results of an international, randomized, controlled study.分化型甲状腺癌患者经重组人促甲状腺素预处理后甲状腺残余组织的放射性碘消融：一项国际随机对照研究的结果
J Clin Endocrinol Metab. 2006 Mar;91(3):926-32. doi: 10.1210/jc.2005-1651. Epub 2005 Dec 29.